Home › Non-Small Cell Lung Cancer › Michigan › Farmington Hills
Non-Small Cell Lung Cancer clinical trials in Farmington Hills, MI
13 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Farmington Hills (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Corewell Health Farmington Hills Hospital, Farmington Hills
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi away
- Henry Ford Medical Center-Columbus, Novi · 5 mi away
- and 2 more
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi away
- Henry Ford Health Providence Southfield Hospital, Southfield · 8 mi away
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RecruitingPhase 1
- ALX Center 8, Farmington Hills
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RecruitingPhase 2
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi away
- Henry Ford Health Providence Southfield Hospital, Southfield · 8 mi away
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RecruitingPhase 3
- Research Site, Farmington Hills
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Profound Research, LLC, Farmington Hills
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- Profound Research, LLC, Farmington Hills
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecruitingPhase 3
- Weisberg Cancer Treatment Center, Farmington Hills
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RecruitingPhase 1
- Karmanos Cancer Institute, Farmington Hills
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RecruitingPhase 2
- Oakland Medical Group, Farmington Hills
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Henry Ford Medical Center-Columbus, Novi · 5 mi away
- Henry Ford West Bloomfield Hospital, West Bloomfield · 6 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Henry Ford Medical Center-Columbus, Novi · 5 mi away
- Henry Ford West Bloomfield Hospital, West Bloomfield · 6 mi away
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
RecruitingPhase 1/2
- Research Site, Farmington Hills
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Farmington Hills
- Parkinson's Disease13 studies
- Obesity12 studies
- Overweight10 studies
- Breast Cancer10 studies
- Heart Failure9 studies
- Lung Cancer8 studies
- Prostate Cancer8 studies
- Alzheimer's Disease8 studies
- Bladder Cancer6 studies
- Multiple Sclerosis6 studies
- COPD6 studies
- Mild Cognitive Impairment6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.